Skip to content
Lower risk Medical device recall · FDA · Published May 17, 2021

Smiths Medical Insulin Syringe Recall: Skewed Graduations Risk Inaccurate Dose

Smiths Medical recalls specific insulin syringes with skewed graduation markings that may cause inaccurate insulin doses. Affected models include 1.0mL 28G and 29G syringes with certain lot numbers. Consumers should check their syringes for upward skewing of markings.

🇺🇸 FDA recall #Z-1798-2021Medical deviceSmiths Medical ›
Take action

Contact the company

Recalling firmSmiths Medical ASD Inc.6000 Nathan Ln N · Minneapolis, MN 55442-1690
✎ GovInfoNow plain-language explainer

Smiths Medical is recalling specific insulin syringes that have graduation markings skewed upward by about 20 degrees. This could lead to inaccurate insulin dosing, which might cause health risks for people using insulin. The recall affects certain model numbers and lot numbers. Read more at govinfonow.com/recall/62535-smiths-medical-insulin-syringe-recall-skewed-graduations-risk-inaccurate-dose.

Source Summary by GovInfoNow · govinfonow.com/recall/62535-smiths-medical-insulin-syringe-recall-skewed-graduations-risk-inaccurate-dose · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1798-2021

Cite this page

“Smiths Medical Insulin Syringe Recall: Skewed Graduations Risk Inaccurate Dose.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62535-smiths-medical-insulin-syringe-recall-skewed-graduations-risk-inaccurate-dose. Based on FDA recall #Z-1798-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1798-2021%22&limit=1).

The FDA announced on May 17, 2021, that Smiths Medical ASD Inc. is recalling specific lots of Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes because graduation markings were skewed approximately 20 degrees upward. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • Brand: Smiths Medical
  • Product: Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringe
  • Model/Ref: 1.0mL 28G X 1/" (0.33mm x 13mm), REF 4428-1
  • Model/Ref: 1.0mL 29G X 1/" (0.33mm x 13mm), REF 4429-1
  • Lot Numbers (REF 4428-1): 4046543, 4062235
  • Lot Numbers (REF 4429-1): 4031846, 4031845, 4040734, 4043536, 4046545, 4046546, 4062239, 4062240, 4062238, 4062242, 4014096
  • Units Affected: 1,432,200

The hazard

According to the FDA, specific models and lot numbers of the Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringe had odd number line graduation markings on the syringe barrel that were skewed approximately 20 degrees upward.

Context

GovInfoNow's records show Smiths Medical ASD, Inc. has 73 other recalls on record since June 5, 2017. Other recent recalls of similar products include the Smiths Medical CADD Solis VIP Infusion Pump Recall for potential thermal damage (April 10, 2025) and false alarm risk (April 10, 2025), as well as the Smiths Medical CADD Solis HSPCA Pump recall for wireless connection alarms risking serious injury (April 10, 2025).

How to tell if you have this one

Check for syringes with 1.0mL capacity, 28G or 29G needles, and a specific reference number (4428-1 or 4429-1). Look for upward skewing of the graduation markings on the barrel.

  • Brand
    Smiths Medical
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Syringe Markings

    Inspect the syringe barrel for upward skewing of graduation markings by about 20 degrees.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the countries of UK, Spain.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2.4 years after the firm started it.

1. Firm started the recall: May 17, 202112. FDA classified it Class I: Jun 10, 202123. Published in FDA’s Enforcement Report: Jun 16, 202134. FDA terminated the recall: Oct 11, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Smiths Medical recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1798-2021 (May 17, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1798-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.